Literature DB >> 14523046

IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Onder Alpdogan1, Stephanie J Muriglan, Jeffrey M Eng, Lucy M Willis, Andrew S Greenberg, Barry J Kappel, Marcel R M van den Brink.   

Abstract

We used clinically relevant murine allogeneic bone marrow transplantation (BMT) models to study the mechanisms by which IL-7 administration can improve posttransplant peripheral T cell reconstitution. After transplant we could distinguish two populations of mature donor T cells: (a) alloreactive T cells with decreased expression of CD127 (IL-7 receptor alpha chain) and (b) nonalloreactive T cells, which express CD127 and undergo homeostatic proliferation. IL-7 administration increased the homeostatic proliferation of nonalloreactive T cells, but had no effect on alloreactive T cells and the development of graft-versus-host disease. Allogeneic transplant of purified hematopoietic stem cells and adoptive transfer of thymocytes into lethally irradiated hosts suggested that recent thymic emigrants can undergo homeostatic proliferation and acquire a memory-like phenotype. We found by BrdU pulse-chase, cell cycle, and annexin V analyses that IL-7 administration has significant proliferative and antiapoptotic effects on posttransplant peripheral T cells. We conclude that homeostatic expansion is important for T cell reconstitution after allogeneic BMT and involves both transferred mature T cells and recent thymic emigrants. Apart from its thymopoietic effects, IL-7 promotes peripheral T cell reconstitution through its selective proliferative and antiapoptotic effects on nonalloreactive and de novo-generated T cells, but has no effect on alloreactive T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523046      PMCID: PMC198519          DOI: 10.1172/JCI17865

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  80 in total

Review 1.  The generation and fate of thymocytes.

Authors:  K Shortman; M Egerton; G J Spangrude; R Scollay
Journal:  Semin Immunol       Date:  1990-01       Impact factor: 11.130

2.  T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny.

Authors:  C L Mackall; L Granger; M A Sheard; R Cepeda; R E Gress
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

3.  IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets.

Authors:  R Murray; T Suda; N Wrighton; F Lee; A Zlotnik
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

4.  Determination of lymphocyte division by flow cytometry.

Authors:  A B Lyons; C R Parish
Journal:  J Immunol Methods       Date:  1994-05-02       Impact factor: 2.303

5.  Cytotoxic and interferon gamma-producing activities of gamma delta T cells in the mouse intestinal epithelium are strain dependent.

Authors:  H Ishikawa; Y Li; A Abeliovich; S Yamamoto; S H Kaufmann; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.

Authors:  D I Marks; J O Cullis; K N Ward; S Lacey; R Syzdlo; T P Hughes; A P Schwarer; E Lutz; A J Barrett; J M Hows; J R Batchelor; J M Goldman
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

7.  In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells.

Authors:  S Okada; H Nakauchi; K Nagayoshi; S Nishikawa; Y Miura; T Suda
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

8.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

Authors:  N A Kernan; G Bartsch; R C Ash; P G Beatty; R Champlin; A Filipovich; J Gajewski; J A Hansen; J Henslee-Downey; J McCullough
Journal:  N Engl J Med       Date:  1993-03-04       Impact factor: 91.245

9.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

Authors:  U von Freeden-Jeffry; P Vieira; L A Lucian; T McNeil; S E Burdach; R Murray
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  66 in total

1.  MCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthood.

Authors:  Jingang Gui; Amanda J Morales; Sophie E Maxey; Katherine A Bessette; Nora R Ratcliffe; John A Kelly; Ruth W Craig
Journal:  Int Immunol       Date:  2011-09-21       Impact factor: 4.823

2.  Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.

Authors:  Craig C Davis; Luciana C Marti; Gregory D Sempowski; Durairaj A Jeyaraj; Paul Szabolcs
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

Authors:  Barry J Kappel; Javier Pinilla-Ibarz; Adam A Kochman; Jeffrey M Eng; Vanessa M Hubbard; Ingrid Leiner; Eric G Pamer; Glen Heller; Marcel R M van den Brink; David A Scheinberg
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 4.  Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation.

Authors:  J L Zakrzewski; A M Holland; M R M van den Brink
Journal:  J Mol Med (Berl)       Date:  2007-02-28       Impact factor: 4.599

5.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 6.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

7.  Shortening the immunodeficient period after hematopoietic stem cell transplantation.

Authors:  Isabelle André-Schmutz; Emmanuelle Six; Delphine Bonhomme; Julien Rouiller; Liliane Dal Cortivo; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 8.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

9.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 10.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.